Baillie Gifford - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$31,839
+23.5%
231
+16.1%
0.00%
Q4 2022$25,786
+17.2%
1990.0%0.00%
Q3 2022$22,000
+46.7%
1990.0%0.00%
Q2 2022$15,000
+7.1%
199
+12.4%
0.00%
Q1 2022$14,000
-12.5%
1770.0%0.00%
Q4 2021$16,0000.0%1770.0%0.00%
Q3 2021$16,0000.0%177
-13.7%
0.00%
Q2 2021$16,000
+6.7%
2050.0%0.00%
Q1 2021$15,000
-50.0%
205
+15.2%
0.00%
Q4 2020$30,0001780.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Evolutionary Tree Capital Management, LLC 68,937$5,138,0003.04%
Avoro Capital Advisors LLC 2,150,000$160,240,0002.77%
Casdin Capital, LLC 550,000$40,992,0001.22%
TOBAM 371,107$27,659,0001.18%
Ikarian Capital, LLC 455,900$33,978,0001.14%
Eventide Asset Management 697,156$51,959,0000.77%
FOX RUN MANAGEMENT, L.L.C. 4,902$365,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,500$2,348,0000.62%
Sivik Global Healthcare LLC 20,000$1,491,0000.54%
Rock Springs Capital Management LP 328,750$24,502,0000.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders